AdvaMed defends FDA's 510(k) clearance process for devices

09/23/2009 | Wall Street Journal, The

The FDA said it commissioned the Institute of Medicine to evaluate its 510(k) clearance process for medical devices and also will conduct an internal assessment of the process. AdvaMed called the 510(k) process "a well-defined, science-driven method used by FDA as part of a comprehensive regulatory framework," and advised IOM to include device experts in the evaluation.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX